Abstract PS5-04-19: 70-gene signature high risk classification provides stronger prognostic value than histologic grade in hr+ her2- early breast cancer
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: E. F. Cobain, L. Pusztai, C. L. Graham, P. D. Beitsch, C. R. C. Osborne, R. L. Rahman, N. M. Johnson, A. Brufsky, R. L. Mahtani, V. K. Gadi, K. Hoskins, H. M. Linden, R. A. Mukhtar, E. A. Brown, L. P. Gold, J. Alberty, S. Benjamin, S. Lee, J. V. Pellicane, H. Ramaswamy, R. Weber, N. Stivers, A. Menicucci, W. Audeh, J. O'Shaughnessy
Institutions: University of Michigan, Michigan Medicine, Yale University, Dallas Surgical Group, Texas Tech University, Legacy Health, University of Pittsburgh, Baptist Hospital of Miami, University of Illinois Chicago, Fred Hutch Cancer Center, University of California, San Francisco, State University of New York, SUNY Downstate Health Sciences University, Upstate University Hospital, Agendia (United States)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129642756
Cites:
Cited by:
Related to:
